Pronethalol

From Self-sufficiency
Revision as of 19:41, 23 August 2010 by ChemNerd (Talk)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Pronethalol
File:Pronethalol.svg
Systematic (IUPAC) name
1-(naphthalen-2-yl)-2-(propan-2-ylamino)ethanol
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Uncontrolled
Identifiers
CAS Number 51-02-5
ATC code none
PubChem CID 4930
ChemSpider 4761
Chemical data
Formula C15H19NO
Molar mass 229.32 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Pronethalol (Alderlin, Nethalide) was an early non-selective beta blocker clinical candidate. It was never used clinically due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite.[1]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Stapleton MP (1997). "Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology". Tex Heart Inst J. 24 (4): 336–42. PMC 325477Freely accessible. PMID 9456487.